TrialCancer chemotherapy and pharmacology2013

Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.

Elisabeth G Vichaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.